Carregant...
Blocking CCN2 Preferentially Inhibits Osteoclastogenesis Induced by Repetitive High Force Bone Loading
PURPOSE/AIM. We recently found that blocking CCN2 signaling using a monoclonal antibody (FG-3019) may be a novel therapeutic strategy for reducing overuse-induced tissue fibrosis. Since CCN2 plays roles in osteoclastogenesis, and persistent performance of a high repetition high force (HRHF) lever pu...
Guardat en:
| Publicat a: | Connect Tissue Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189320/ https://ncbi.nlm.nih.gov/pubmed/32683988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/03008207.2020.1788546 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|